IceCure Medical (ICCM) vs VolitionRX (VNRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
VolitionRX is the larger company by market cap ($6.6 million vs $5.2 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICCM | VNRX |
|---|---|---|
| Share price | $1.13 | $0.2194 |
| Market cap | $5.24M | $6.60M |
| 1-day change | -1.74% | -2.92% |
| EPS (TTM) | $-6.84 | $-3.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.30 | $10.40 |
| 52-week low | $1.05 | $0.217 |
| Distance from 52-week high | -96.27% | -97.89% |
| Analyst consensus | none | none |
| Avg. price target upside | +1906.19% | +6107.84% |
| Average volume | 136.91K | 8.47M |
| Shares outstanding | 4.64M | 30.06M |
| Employees | 67 | 57 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About IceCure Medical
ICCM stock →IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
Healthcare · Medical Devices · 67 employees
About VolitionRX
VNRX stock →VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.
Healthcare · Medical Devices · 57 employees
ICCM vs VNRX FAQ
Which is bigger, IceCure Medical or VolitionRX?
VolitionRX (VNRX) is larger, with a market capitalization of $6.60M compared with $5.24M for IceCure Medical (ICCM).
Are IceCure Medical and VolitionRX in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.